Navigation Links
MEDai's Predictive Analytics Impact How State Medicaid Agencies Triage High- Risk Members
Date:9/11/2008

ORLANDO, Fla., Sept. 11 /PRNewswire/ -- MEDai, Inc., headquartered in Orlando, FL, a leading provider of advanced solutions for healthcare that utilize award-winning predictive analytics, announced today that at the upcoming MMIS 2008 Conference in Nashville, TN, one of its clients, a state Medicaid Agency, will be presenting how predictive analytics, specifically MEDai's Risk Navigator Clinical(R), has impacted its overall strategy and efforts.

The presentation will demonstrate how MEDai's predictive modeling tool can turn claims data into actionable information for a public agency. The agency will discuss lessons learned, data challenges and results to date.

"MEDai has several state Medicaid agencies that leverage our analytics to better triage high-risk members into the appropriate care management programs," said Swati Abbott, president of MEDai. "Having an accurate and effective way to allocate resources is paramount at a time when public agencies are seeing healthcare costs skyrocket," she added.

For more than a decade, MEDai's predictive modeling applications have accurately forecasted prospective high-risk patients to improve patients' health and quality of care while controlling cost. MEDai's suite of predictive modeling solutions addresses the needs of health plans, employers, physicians, underwriters, and actuaries. Wrapping business intelligence around a patient-centric database allows Risk Navigator Clinical to bridge the gap between clinical and financial objectives, providing a consistent approach to strategically managing medical and revenue enhancement opportunities.

About MEDai

MEDai, Inc. is a leading health information company offering award-winning solutions for improvement of healthcare delivery. Utilizing cutting-edge technology, payors and care management organizations are able to predict patients at risk, identify cost drivers for their high-risk population, forecast future health plan costs, evaluate
'/>"/>

SOURCE MEDai, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MEDai Demonstrates the Value of Implementing Predictive Analytics
2. MEDai Assists Healthcare Organizations Demonstrate the Value of Predictive Modeling
3. Biopsy techniques have made PSA test less predictive
4. Sixteen Organizations Implement ACG Rx-PM Predictive Modeling from Johns Hopkins University, DST Health Solutions
5. Early predictive model may be new weapon against leading cause of death on battlefield
6. HighPoint Solutions to Develop Contract Analytics Solution for a Top Three Pharmaceutical Company
7. Kognitio CEO Offers Outsourced, Service-Based Data Warehousing as a New Approach to Large Scale Analytics
8. Wolters Kluwer Health Introduces Formulary Facts(TM), a Formulary Analytics Tool that Sets the Standard for Accuracy and Ease-of-Use
9. PointOne Launches New Business Direction, Healthcare Analytics Beyond Hospitals
10. Milliman Announces Encore Webinar on Practical Uses of Lifestyle-Based Analytics (LBA) in Risk Selection
11. Milliman Expert Addresses Practical Applications of Lifestyle-Based Analytics in Risk Selection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2009)Wind Turbines are popping up in the most unusual places, and to do everything from growing mushrooms, making wine to keeping prisoners in jail! , (PRWEB) December 5, 2009 -- W
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)KANSAS CITY, Mo., Dec. 4 The large, two-day free health clinic sponsored by the National Association of Free Clinics (NAFC) in Kansas City on Wednesday and Thursday is not just for the sick but also
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
... Oct. 6 HealthSouth,Corporation (NYSE: HLS ) tod...zed investor meeting in New York City. Presentatio...T at the Grand Hyatt New York, located at,109 E. 4... -- HealthSouth Overview and Industry...
...6 The United States has,intervened in a lawsuit a...ted false claims to Medicare arising from illegal ...dical equipment (DME) suppliers, the,Justice Depar...ry LLC, Beverly Enterprises Inc., CERES Strategies...
... Developed in collaboration with,Siemens(R), Axis...cing,Revolutionary Breast Surface Imaging and Morp... Dr. Steve Laverson this week in Encinitas, CA.,Th...prietary software. The XS-300(TM) platform photogr...
...ct. 6 Ohio,s academic health care,industry contri..., an,increase of approximately $16.5 billion since...ing one in 12 Ohioans, according to a recent study...n, the report underscores the significant role,Ohi...
... Millions of women suffer with symptoms o...ion economic rescue plan. But the effects of our c...ome making it increasingly difficult for U.S. wome...hout a prescription. , La...
..., Oct. 6 SAP AG (NYSE: SAP ),today announced tha...sident,of the Healthcare industry business unit. I...andrea will help drive SAP,s industry leadership,e...nnual Ambassadors Dinner and the U.S.-EU eHealth C...
Other Medicine News:Health News:HealthSouth to Hold Investor Meeting November 10, 2008 2Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Plan Your Breasts in 3-D 2Health News:Academic Medicine Means Business for Ohio: $37.2 Billion Economic Impact for the State 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3
(Date:12/4/2009)TARRYTOWN, N.Y., Dec. 4 Bayer Diabetes Care today announced the three grand prize winners of Bayer,s "Express Your Simple Win Creativity Contest." Nick Jonas, of the Jonas Brothers, selected the winn
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced today that the US Patent and Trademark Office has allowed its patent application o
(Date:12/4/2009)RARITAN, N.J., Dec. 4 Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Fastrack Clients Realize Substantial Benefits from On Line Training 60134 1Fastrack Clients Realize Substantial Benefits from On Line Training 60134 2Ross University School of Medicine Recognized for Commitment to Public Service and Civic Leadership 60132 1Ross University School of Medicine Recognized for Commitment to Public Service and Civic Leadership 60132 2An Alternative To Adderall 3F 60130 1An Alternative To Adderall 3F 60130 2An Alternative To Adderall 3F 60130 3
...ll Doses of VYVANSE Studied Demonstrated Significa... of Daily Treatment, BOSTON, Oct. 25 Shire plc (...cialty biopharmaceutical company, today,announced ...lts with,Attention Deficit Hyperactivity Disorder ...D symptom control within one week of treatment wit...
...ignificant Survival Advantage Shown in Lung Cancer...Nasdaq: ENMD ), a clinical-stage pharmaceutical c...f cancer and inflammatory diseases, today,announce...tic results for,its antimitotic agent, ENMD-1198, ...ts. The data were presented at the AACR-NCI-EORTC,...
Other Medicine Technology:Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 2Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 3Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 4Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 5Results of VYVANSE(TM) (lisdexamfetamine dimesylate) Pivotal Trial in Adult ADHD Presented at Major Scientific Meeting 6EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198 2EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198 3
... Clear Plus™ Uncuffed Endotracheal Tube w. F...et inside. Sterile, Single use. A quality Rusch en... is ready to use saving you time and storage space...ate smooth withdrawal. It is designed with a soft ...
Slick Set® Uncuffed
Cuffed Nasoral Magill
...ubber tube with Murphy eye. Laser resistant foam s...uffs (One inside other) 40cm (16") long, Single Us...access and optimum visibility within the operating...he tube shaft has a special laser-guard of approx....
Medicine Products: